The medical and surgical management of pseudoexfoliation glaucoma.
作者信息
Desai Manishi A, Lee Richard K
机构信息
Bascom Palmer Eye Institute, Miami, FL 33136, USA.
出版信息
Int Ophthalmol Clin. 2008 Fall;48(4):95-113. doi: 10.1097/IIO.0b013e318187e902.
Abstract
摘要
相似文献
1
The medical and surgical management of pseudoexfoliation glaucoma.
Int Ophthalmol Clin. 2008 Fall;48(4):95-113. doi: 10.1097/IIO.0b013e318187e902.
2
Surgical management of pseudoexfoliation glaucoma.
Int Ophthalmol Clin. 2014 Fall;54(4):71-83. doi: 10.1097/IIO.0000000000000041.
3
Conjunctival inflammatory cells and their predictive role for deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma.
J Glaucoma. 2011 Mar;20(3):172-8. doi: 10.1097/IJG.0b013e3181d9ccb0.
4
Ab interno gel implant in patients with primary open angle glaucoma and pseudoexfoliation glaucoma.
BMC Ophthalmol. 2018 Dec 27;18(1):339. doi: 10.1186/s12886-018-0989-6.
5
Spectrum of new patients presenting to a tertiary glaucoma unit in Vietnam.
Clin Exp Ophthalmol. 2019 May;47(4):548-550. doi: 10.1111/ceo.13426. Epub 2018 Nov 28.
6
Two-year outcome of repeat trabeculectomy with mitomycin C in primary open-angle and PEX glaucoma.
Eur J Ophthalmol. 2015 May-Jun;25(3):185-91. doi: 10.5301/ejo.5000542. Epub 2014 Dec 1.
7
Pseudoexfoliation syndrome and pseudoexfoliative glaucoma.
Optometry. 2004 Apr;75(4):245-50. doi: 10.1016/s1529-1839(04)70052-4.
8
Current concepts in the pathogenesis and management of exfoliation syndrome and exfoliative glaucoma.
Compr Ophthalmol Update. 2006 May-Jun;7(3):131-41.
9
Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab: A Randomized Controlled Trial.
J Glaucoma. 2016 Mar;25(3):e182-8. doi: 10.1097/IJG.0000000000000202.
10
Ocular decompression retinopathy after deep sclerectomy with mitomycin C in an eye with exfoliation glaucoma.
Eur J Ophthalmol. 2011 May-Jun;21(3):324-7. doi: 10.5301/EJO.2010.5731.
引用本文的文献
1
Management outcomes and clinical features of combined exfoliation syndrome with angle closure glaucoma.
Sci Rep. 2025 Jun 5;15(1):19799. doi: 10.1038/s41598-025-04489-0.
2
Presence of pseudoexfoliation-like material in young patients.
Indian J Ophthalmol. 2025 May 1;73(5):764-768. doi: 10.4103/IJO.IJO_1998_24. Epub 2025 Apr 24.
3
The Ocular Surface and the Anterior Segment of the Eye in the Pseudoexfoliation Syndrome: A Comprehensive Review.
Int J Mol Sci. 2025 Jan 10;26(2):532. doi: 10.3390/ijms26020532.
4
Genetic background determines severity of Loxl1-mediated systemic and ocular elastosis in mice.
Dis Model Mech. 2023 Nov 1;16(11). doi: 10.1242/dmm.050392. Epub 2023 Nov 13.
5
Beyond the Dusty Fog: Local Eye Drop Therapy and Potentially New Treatment Alternatives in Pseudoexfoliative Glaucoma.
Curr Med Chem. 2024;31(13):1608-1619. doi: 10.2174/0109298673255220231010073215.
6
Role of ripasudil as an adjunct treatment in the management of pseudoexfoliative glaucoma.
Indian J Ophthalmol. 2023 Jul;71(7):2756-2759. doi: 10.4103/IJO.IJO_659_23.
7
Clinical profile and demographic distribution of pseudoexfoliation syndrome: An electronic medical record-driven big data analytics from an eye care network in India.
Indian J Ophthalmol. 2023 Jul;71(7):2746-2755. doi: 10.4103/IJO.IJO_2619_22.
8
Long-Term Evaluation of Pseudoexfoliation Syndrome Post-Cataract Extraction.
J Pers Med. 2023 May 12;13(5):818. doi: 10.3390/jpm13050818.
9
Risk factors for intraocular pressure elevation following Descemet membrane endothelial keratoplasty in Asian patients.
Graefes Arch Clin Exp Ophthalmol. 2023 Mar;261(3):749-760. doi: 10.1007/s00417-022-05835-y. Epub 2022 Sep 20.
10
Canaloplasty in Pseudoexfoliation Glaucoma. Can It Still Be Considered a Good Choice?
J Clin Med. 2022 Apr 30;11(9):2532. doi: 10.3390/jcm11092532.
本文引用的文献
1
The molecular pathophysiology of pseudoexfoliation glaucoma.
Curr Opin Ophthalmol. 2008 Mar;19(2):95-101. doi: 10.1097/ICU.0b013e3282f49cda.
2
Evaluation of the acoustic function in pseudoexfoliation syndrome and exfoliation glaucoma: audiometric and tympanometric findings.
Eur J Ophthalmol. 2008 Jan-Feb;18(1):71-6. doi: 10.1177/112067210801800112.
3
Sensorineural hearing loss in pseudoexfoliation syndrome.
Ophthalmology. 2008 Mar;115(3):425-9. doi: 10.1016/j.ophtha.2007.10.038. Epub 2008 Jan 9.
4
Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma.
Science. 2007 Sep 7;317(5843):1397-400. doi: 10.1126/science.1146554. Epub 2007 Aug 9.
5
Predictors of long-term progression in the early manifest glaucoma trial.
Ophthalmology. 2007 Nov;114(11):1965-72. doi: 10.1016/j.ophtha.2007.03.016. Epub 2007 Jul 12.
6
A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucoma.
Curr Med Res Opin. 2007 May;23(5):1025-32. doi: 10.1185/030079907x182149.
7
Sensorineural hearing loss in pseudoexfoliation.
Can J Ophthalmol. 2007 Feb;42(1):56-9.
8
The risk of glaucoma in pseudoexfoliation syndrome.
J Glaucoma. 2007 Jan;16(1):117-21. doi: 10.1097/01.ijg.0000243470.13343.8b.
9
Correlation of capsular pseudoexfoliation material and iridocorneal angle pigment with the severity of pseudoexfoliation glaucoma.
J Glaucoma. 2007 Jan;16(1):94-7. doi: 10.1097/01.ijg.0000212283.70422.b0.
10
Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up.
Am J Ophthalmol. 2007 Jan;143(1):9-22. doi: 10.1016/j.ajo.2006.07.020. Epub 2006 Sep 1.
Zotero 插件